Oxygen free radicals are highly reactive compounds causing peroxldation of lipids and proteins and are thought to play an important role in the pathogenesis of reperfusion abnormalities including myocardial stunning, irreversible injury, and reperfusion arrhythmias. Free radical accumulation has been measured in ischemic and reperfused myocardium directly using techniques such as electron paramagnetic resonance spectroscopy and tissue chemiluminescence and indirectly using biochemical assays of lipid peroxidation products. Potential sources of free radicals during ischemia and reperfusion have been identified in myocytes, vascular endothelium, and leukocytes. In several different experimental models exogenous free radical-generating systems have been shown to produce alterations in cardiac function that resemble the various reperfusion abnormalities described above. Injury to processes involved in regulation of the intracellular Ca 1+ concentration may be a common mechanism underlying both free radical-induced and reperfusion abnormalities. Direct effects of free radicals on each of the known Ca 2+ -regulating mechanisms of the cell as well as the contractile proteins and various ionic membrane currents have been described. Free radicals also inhibit critical enzymes in anaerobic and aerobic metabolic pathways, which may limit the metabolic reserve of reperfused myocardium and contribute to intracellular Ca 2+ overload. Inhibiting free radical accumulation during myocardial ischemia/reperfusion with free radical scavengers and inhibitors has been demonstrated to reduce the severity of myncardial stunning, irreversible injury, and reperfusion arrhythmias in many, but not all, studies. This evidence strongly implicates free radical accumulation during myocardial ischemia/reperfusion as an important pathophysiological mechanism of reperfusion abnormalities, although many issues remain unresolved. in the pathogenesis of tissue injury in a variety of organ systems. The role of OFRs in the setting of myocardial ischemia/reperfusion has been of particular interest since advances in technology have now made it possible to intervene clinically in the process of acute myocardial infarction by lysing coronary arterial thrombi with thromboh/tic agents, by mechanically reopening coronary artery obstructions with percutaneous transluminal coronary angioplasty (PTCA), or by surgically bypassing the obstructions. In general, reperfusion after brief periods of ischemia (less than 5-10 minutes) results in immediate and complete recovery of cardiac function, whereas longer periods (10-20 minutes) are
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Oxygen free radicals are highly reactive compounds causing peroxldation of lipids and proteins and are thought to play an important role in the pathogenesis of reperfusion abnormalities including myocardial stunning, irreversible injury, and reperfusion arrhythmias. Free radical accumulation has been measured in ischemic and reperfused myocardium directly using techniques such as electron paramagnetic resonance spectroscopy and tissue chemiluminescence and indirectly using biochemical assays of lipid peroxidation products. Potential sources of free radicals during ischemia and reperfusion have been identified in myocytes, vascular endothelium, and leukocytes. In several different experimental models exogenous free radical-generating systems have been shown to produce alterations in cardiac function that resemble the various reperfusion abnormalities described above. Injury to processes involved in regulation of the intracellular Ca 1+ concentration may be a common mechanism underlying both free radical-induced and reperfusion abnormalities. Direct effects of free radicals on each of the known Ca 2+ -regulating mechanisms of the cell as well as the contractile proteins and various ionic membrane currents have been described. Free radicals also inhibit critical enzymes in anaerobic and aerobic metabolic pathways, which may limit the metabolic reserve of reperfused myocardium and contribute to intracellular Ca 2+ overload. Inhibiting free radical accumulation during myocardial ischemia/reperfusion with free radical scavengers and inhibitors has been demonstrated to reduce the severity of myncardial stunning, irreversible injury, and reperfusion arrhythmias in many, but not all, studies. This evidence strongly implicates free radical accumulation during myocardial ischemia/reperfusion as an important pathophysiological mechanism of reperfusion abnormalities, although many issues remain unresolved. in the pathogenesis of tissue injury in a variety of organ systems. The role of OFRs in the setting of myocardial ischemia/reperfusion has been of particular interest since advances in technology have now made it possible to intervene clinically in the process of acute myocardial infarction by lysing coronary arterial thrombi with thromboh/tic agents, by mechanically reopening coronary artery obstructions with percutaneous transluminal coronary angioplasty (PTCA), or by surgically bypassing the obstructions. In general, reperfusion after brief periods of ischemia (less than 5-10 minutes) results in immediate and complete recovery of cardiac function, whereas longer periods (10-20 minutes) are arrhythmias, may also be modifiable by altering the conditions of reperfusion. 7 Thus, the act of reperfusion appears to contribute additrvefy and possibly independently to the effects of ischemia in creating reversible postischemic cardiac dysfunction, irreversible injury, and reperfusion arrhythmias.
Several lines of evidence suggest that OFRs may play an important role in the pathogenesis of the reperfusion abnormalities described above. It is well documented by several techniques that tissue OFR levels increase markedly upon reperfusion of ischemic heart. Also, in the absence of ischemia/reperfusion, exposure of hearts to OFR-generating systems causes irreversible cardiac injury similar to that caused by ischemia/reperfusion and precipitates nonreentrant arrhythmias similar to reperfusion arrhythmias. Finally, when accumulation of OFRs during ischemia/reperfusion is reduced either by pharmacologically inhibiting OFR production or increasing the antioxidant defenses with OFR scavengers, the severity of myocardial stunning, irreversible injury, and reperfusion arrhythmias has been reduced in many, but not all, studies.
In this review, we begin by discussing the biochemistry of OFR metabolism followed by summarizing the evidence that OFR accumulation occurs during ischemia/ reperfusion. The next section discusses the effects of exogenous OFR-generating systems on cardiac function, with an emphasis on the underlying mechanisms, particularly with respect to effects of OFRs on intracellular Ca 2+ regulation and metabolism. Evidence that OFR inhibitors and scavengers reduce the severity of reperfusion abnormalities is then briefly summarized. We conclude by addressing clinical issues relevant to the role of OFRs in reperfusion abnormalities. The purpose is not to exhaustively review this extensive body of information, but to point out what we consider to be important and still unresolved issues concerning the OFR hypothesis as it relates to cardiac ischemia/reperfusion.
Biochemistry of Oxygen Free Radical Metabolism
OFRs constitute a class of chemical compounds in which an unpaired electron occupies the outer orbital of the oxygen molecule. OFRs are normal by-products of aerobic metabolism produced by the univalent reduction of O 2 to H 2 O, generating the superoxide anion radical (• O 2~) . This pathway accounts for approximately 5% of normal aerobic metabolism. 8 The • O 2c an reduce transition metals (M), such as Fe 3+ or Cu 3+ , in a Haber-Weiss reaction:
The reduced metal in turn reduces hydrogen peroxide (H 2 O 2 ), generated from the dismutation of • O 2~ by endogenous superoxide dismutase (SOD), by means of a Fenton reaction to form the hydroxyl radical (• OH):
The • OH is thought to be the most directly cytotoxic species of OFR, 9 and because of its highly unstable chemical properties, • OH is likely to react within a very close radius (on a molecular scale) to its site of formation. Thus, initially • OH-induced injury is likely to occur at localized cellular sites where transition metals are present (e.g., in mitochondria with their metalcontaining cytochromes and other membrane or cytcsolic proteins and enzymes The cytotoxic effects of OFRs are thought to be due to the peroxidation of cellular lipids and proteins. 12 A free radical owes its biological activity to the unpaired electron in its outer orbital. This unpaired electron is highly unstable and is readily donated to endogenous cellular lipids and proteins to form peroxy derivatives. Oxidation of lipid and protein components of the cell may affect cellular function by multiple mechanisms. Early selective effects of OFRs may be mediated by changes in the lipid microenvironment of membraneassociated proteins or by direct oxidation of amino acids and sulf hydryl groups of proteins, causing loss of enzyme activity and altered function of ion channels, transporters, and receptors. Later nonselective effects may be caused by loss of sarcolemmal and intracellular membrane integrity.
Several events take place during myocardial ischemia that result in increased accumulation of OFRs. Endogenous OFR scavenger levels decrease, 13 reducing myocardial antioxidant defenses. OFR production may increase by several mechanisms (Figure 1 ). In addition to • O 2~ production associated with a low level of ongoing aerobic mitochondrial metabolism during ischemia, • O 2~ may be formed in the conversion of hypoxanthine to uric acid by the enzyme xanthine oxidase. Ordinarily, the activity of xanthine oxidase is very low in heart and conversion of hypoxanthine to uric acid is catalyzed by the enzyme xanthine dehydrogenase in a reaction that does not produce any OFR species. During ischemia, however, elevated intracellular Ca 2+ levels ([Ca 2+ ]i) may promote the conversion of xanthine dehydrogenase to xanthine oxidase. In addition hypoxanthine, a breakdown product of adenosine triphosphate (ATP) hydrolysis, accumulates substantially in ischemic myocardium. 
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is not certain whether OFR generaliuu by this mechanism is quantitatively significant. Endothelial cells contain xanthine oxidase and can also produce OFRs by a distinct pathway involving the free radical nitric oxide (NO •), one of the major components of endotheliumderived relaxing factor. It has recently been demonstrated that NO • readily reacts with • O 2~ to form the peroxynitrite anion (ONOO"), a highly cytotoxic species. 16 In addition, ONOO" can further decompose to form • OH and NO 2 in a metal-independent reaction. Elevation of [Ca 2+ ], during ischemia may also activate phospholipase C to stimulate arachidonic acid metabolism, which generates OFRs as by-products. 17 Autooxidation of mitochondrial enzymes such as fiavoproteins and ubisemiquinones and of catecholamines during ischemia have also been linked to the formation of • O 2~. During ischemia and reperfusion, infiltration of the microvasculature with neutrophils may be another important major source of increased OFR generation. 18 Neutrophils produce several different kinds of OFRs including • O 2 ", H 2 Oi, • OH, and hypochlorous anion (OC1~), a highly reactive species, 19 -20 which are stored in granules within the cytoplasm of the neutrophil and are released in the inflammatory response to ischemia. Thus, a number of individual processes, some localized to the extracellular space, some to endothelial cells, and some to the cytosol of cardiac myocytes, may all contribute to increased OFR production during ischemia/reperfusion. The extent to which the site of generation of • O 2~ and H 2 O 2 (i.e., intracellular versus extracellular) is important to myocardial cytotoxicity is not clear at the present time. Both • O 2~ and H 2 O 2 have longer half-lives than • OH and can readily permeate cell membranes, either directly (H 2 O 2 ) or through anion channels (• O 2~) . Thus, it is likely that • O 2~ and H 2 O 2 generated extracellularly (e.g., by neutrophils or the endothelium) can cause selective myocardial injury before loss of sarcolemmal integrity by diffusing intracellularly and reacting at cytosolic metal-containing sites to form • OH. A similar mechanism may explain how exogenousry delivered OFR scavengers such as SOD and catalase, which are unable to penetrate the cell membrane, are nevertheless effective at reducing the severity of cardiac reperfusion abnormalities. By scavenging extracellular • O 2~ and H 2 O 2 , these agents would create a gradient for efflux of OFRs from the cytosol, consequently reducing the cytosolic accumulation of OFRs to a level at which intracellular antioxidant defense mechanisms are effective.
Even though myocardial oxygen tension is low during ischemia, sufficient oxygen may still be present to sustain increased OFR production by the various mechanisms described above. During reperfusion, with the sudden reintroduction of high oxygen tensions, much higher levels of OFR production are anticipated, which has been confirmed experimentally. Thus, OFRs are a particularly attractive candidate to explain the component of cellular dysfunction and injury attributable to the act of reperfusion. Their role in causing injury during ischemia remains more controversial.
Evidence That Oxygen Free Radicals Accumulate
During Ischemia and Reperfusion Classically, the production of OFRs during ischemia/ reperfusion was inferred from biochemical measurements of lipid peroxidation products, especially malondialdehyde and conjugated dienes. 12 Recently, more sophisticated means of studying the formation of OFRs have been developed. The most direct method is electron paramagnetic resonance (EPR) spectroscopy. While there are potential artifacts using this technique in freeze-clamped myocardial tissue samples from ischemic and reperfused heart, FIGURE 
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Line graph shows time course of oxygen free radical generation during ischemia and reperfusion measured by electron paramagnetic resonance spectroscopy in isolated rabbit hearts with (o, solid lines) and without (A, dashed lines) recombinant human superoxide dismutase. Each point corresponds to measurements of oxygen-centered free radical signal performed on hearts freeze-clamped at different times. Reproduced from Zweier et at 77 by copyright permission of the American Society for Clinical Investigation.
rabbit hearts increased about threefold after 10 minutes of ischemia and over sevenfold within the first few minutes of reperfusion, remaining significantly elevated for more than an hour (Figure 2) . 23 The secondary increase in OFRs during reperfusion has been termed the free radical "burst" and is facilitated by the sudden readmission of oxygen, which fuels all the OFR-generating pathways. It has also been possible to monitor tissue OFR production nondestructively in coronary venous effluent by trapping OFRs that would otherwise decay too quickly to be detected using spin traps such as a-phenyl-VV-terbutylnitrone. The more stable spin trap adducts can then be measured directly in coronary venous effluent by EPR. Spin trap studies have consistently documented an increase in OFR levels during reperfusion but have not always detected elevated OFR levels during ischemia. 24 -26 Other investigators have used oxidation-induced tissue chemiluminescence to monitor changes in OFR levels during ischemia/reperfusion. 27 The resolution of this technique has been considerably improved by including in the coronary perfusate enhancing agents that emit light when oxidized, and significant increases in chemiluminescence have been detected during early reperfusion using this method. 27 However, tissue chemiluminescence was found to decrease during ischemia, suggesting a fall in OFR levels. 27 Thus, although all methods of detecting OFRs show a marked increase in OFR levels during early reperfusion, whether OFR levels increase during ischemia remains controversial. This point is obviously of major importance for determining whether OFRs contribute to cardiac injury sustained during the ischemic period as well as during reperfusion.
Effects of Oxygen Free Radical-Generating Systems on Cardiac Function
In addition to demonstrating OFR accumulation dur-~~-* ing ischemia/reperfusion, a second criterion supporting the general plausibility of the OFR hypothesis is the observation that exposure to OFRs in the absence of ischemia/reperfusion can produce similar abnormalities in cardiac function. Experimentally this has been investigated by including various exogenous OFR-generating systems in the coronary arterial perfusate (simulating OFR generation from extracellular sources) or by loading hearts intracellularry with photoactive agents that produce reactive oxygen species when irradiated (simulating OFR generation from intracellular sources).
However, several important caveats should be recognized before attempting to extrapolate these results to ischemia/reperfusion. With both approaches it has been difficult to establish whether the levels of OFRs generated in these experiments are representative of those occurring during ischemia/reperfusion. Also, in addition to generating • O 2~, photoactive agents such as rose bengal generate singlet oxygen radicals, which may not be a prominent species of OFR generated during ischemia/reperfusion (for discussion see Reference 28).
Similarities to Irreversible Reperfusion Injury
Hearts exposed to OFR-generating systems exhibit many features similar to those of ischemia/reperfusion injury, including cellular K + loss, action potential duration shortening leading to inexcitability, loss of developed systolic force, progressive rise in diastolic force (contracture), depressed high-energy phosphate levels, and damage to cellular metabolic machinery ( Figure  3 ]j that preceded major reductions in tissue high-energy phosphate levels (Figure 4) . Importantly, parallel EPR spectroscopy experiments demonstrated that this OFR-generating system produced OFR levels comparable to those in ischemia/reperfusion in the same experimental model. [ exchange.
Similarities to Myocardial Stunning
Whether a less intense initial exposure to OFRgenerating systems and a longer observation period (several days) to assess recovery of contractile and ] o during reperfusion after ischemia has been shown to significantly reduce the severity of myocardial stunning. 6 The contractile abnormalities in myocardial stunning do not appear to result directly from the depressed metabolic state since a normal inotropic response can be obtained with /3-adrenergic receptor stimulation despite no improvement in metabolic parameters. 36 OFR-generating systems have been reported to depress myofibrillar ATPase activity, which could at least partially account for a defect in myofilament Ca 2+ responsiveness. 40 OFR-generating systems have also been shown to directly inhibit glycolytic and oxidative metabolism, 29 consistent with the possibility that the prolonged reversible metabolic defect in stunned myocardium is also related to OFR toxicity.
Similarities to Reperfusion Arrhythmias
It is well documented that exposure of isolated intact heart and single myocytes to OFR-generating systems produces arrhythmias and electrophysiological alterations including membrane depolarization, abnormal automaticity, action potential prolongation followed by shortening, early and late afterdepolarizations, and triggered activity ( Figure 5) . 41~43 Based on these findings, OFR-induced arrhythmias are likely to be nonreentrant in nature, which is the most common mechanism of reperfusion arrhythmias. 4 ]i overload, as discussed in the next section.
Oxygen Free Radicals and Metabolism
OFR-generating systems have been shown to impair the function of isolated mitochondria 65 -66 and to directly inhibit the key gtycoh/tic enzyme gh/ceraldehyde 3-phosphate dehydrogenase. 67 In patch-clamped ventricular myocytes buffered with high internal EGTA concentrations to minimize [Ca 2+ ]| overload, OFR-generating systems were found to inhibit irreversibly both anaerobic gh/colysis and mitochondrial oxidative phosphorylation ( Figure 6) . 29 It is possible that in addition to direct effects on [Ca ] , regulatory processes, OFRs contribute significantly to [Ca ]| overload indirectly by inhibiting cardiac metabolism since [Ca 2+ ]j overload is a wellrecognized consequence of metabolic inhibition. Conversely, [Ca 2+ ]j overload can itself cause damage to the cellular metabolic machinery. Consistent with the former possibility, however, inhibition of gh/colysis was found to precede the increase in [Ca 2+ ], in isolated rabbit hearts exposed to H 2 O 2 and FeCl 2 in the NMR spectroscopy study by Corretti et al. 30 OFR-induced injury to cellular metabolism may be an important factor limiting the ability of reperfused myocardium to recover metabolic and contractile function and ultimately to avoid irreversible injury after reperfusion.
Oxygen Free Radicals and Vascular Dysfunction
Although the above discussion has focused on mechanisms by which myocytes are injured by OFRs, it is likely that vascular function is also significantly compromised by OFRs. The contribution of vascular dysfunction and injury to myocardial reperfusion abnormalities is not resolved at the present time. A commonly held view is that severe vascular abnormalities such as noreflow occur only in areas in which myocytes have already been irreversibly injured. 68 However, whether reduced capacity to generate endothelium-derived relaxing factor (roughly the vascular equivalent of stunning) and other potentially OFR-mediated vascular abnormalities in reperfused heart have important effects on ultimate recovery of postischemic cardiac function is unknown.
Effects of Limiting Oxygen Free Radical
Accumulation on Severity of Reperfusion Abnormalities The findings that OFRs accumulate during ischemia/ reperfusion and that OFR-generating systems can cause abnormalities similar to those associated with ischemia/ reperfusion provide circumstantial evidence supporting a role of OFRs in reperfusion abnormalities. To prove directly that OFR accumulation contributes to reperfusion abnormalities it is necessary to demonstrate that prevention of OFR accumulation during ischemia/ reperfusion reduces the severity of or eliminates reperfusion abnormalities. Examples of agents used to prevent OFR formation include allopurinol and its metabolite oxypurinol (inhibitors of xanthine oxidase), deferroxamine (which chelates iron to prevent Fe 3+ -catalyzed production of • OH), agents that reduce chemoattraction and activation of neutrophils, and leukocyte filtration or inactivation with antiserum. The OFR scavenging capability of the myocardium has been enhanced using SOD, polyethylene glycol-conjugated SOD (PEG-SOD) (to prolong the half-life of SOD), catalase, angiotensin converting enzyme inhibitors containing sulfhydryl groups (including captopril and several of its analogues), dimethylthiourea and N-(2-mercaptopropionyl)gh/cine or mannitol (to scavenge • OH), and of-tocopherol. Many studies have demonstrated that OFR inhibitors or scavengers had a beneficial effect on myocardial stunning, irreversible injury, and reperfusion arrhythmias (for reviews see References 5 and 69). However, negative results have also been obtained in a significant number of studies. For example, Vanhaecke et al 70 subjected 50 dogs to a 90-minute thrombotic coronary occlusion followed by thrombolytic therapy with or without a 1-hour infusion of SOD but found no difference in infarct size, postischemic recovery of contractile function, or tissue high-energy phosphate levels. Tanaka et al 71 obtained similar negative results using an infusion of PEG-SOD for 60 minutes. PEG-SOD has a plasma half-life of more than 30 hours, so SOD levels remained substantially elevated above control levels during the entire 4-day period of reperfusion. In addition, PEG-SOD was supplemented by a 1-hour infusion of catalase. In contrast, a study by Tamura et al 72 using an almost identical experimental model, but a lower dose of PEG-SOD and no catalase, showed a definite limitation in infarct size. The reasons underlying these discrepancies are probably multifactorial, as reviewed by BoUi 73 and Cohen.
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It would be simplistic to assume that OFR accumulation is the only cause of ischemia/reperfusion injury. For example, Hearse and coworkers 75 -76 found that OFRs were only one of several equally malevolent mechanisms predisposing the isolated ischemic rat heart to reperfusion ventricular fibrillation. The authors suggested that interventions selectively reducing OFR accumulation would only unmask these other mechanisms and be unlikely to reduce the overall incidence of lethal reperfusion arrhythmias. The species of animal, the duration of ischemia, the cardiac workload during the ischemic period, and the composition of the coronary perfusate may all be important determinants of the relative contribution of OFR accumulation, as opposed to other factors, to reperfusion abnormalities. Timing of the administration of OFR inhibitors and scavengers, whether before or during the ischemic period or at the moment of reperfusion, may also be critical. Not all studies documented in their protocol whether the OFR scavengers and inhibitors were effective at reducing OFR levels during ischemia/reperfusion under their experimental conditions. Both the specific OFR species scavenged and their sites of production may also be important. For example, certain inhibitors reduce OFR production from only a single pathway (e.g., allopurinol) and would be expected to have no effect on toxicity of OFRs from alternate sources. OFR scavengers may have access to OFRs in only a particular compartment (e.g., exogenous SOD and catalase, which do not penetrate intracellularry). Several studies have directly documented that exogenous SOD reduced OFR accumulation during reperfusion 27 -77 (e.g., Figure 2 ), but in a preliminary report Henry et al 78 found SOD ineffective at reducing the increase in chemiluminescence during reperfusion if hearts were pretreated with 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid to block anion channels, the major pathway for transmembrane • O 2~ movement. These results suggest that in this isolated crystalloid-perfused Langendorflf heart preparation the chemiluminescent signal originated primarily from intracellular OFRs and that efflux of • O 2t hrough anion channels was necessary for exogenously applied SOD to reduce OFR accumulation. Altering cardiac anion channel permeability might be a new approach for reducing OFR accumulation during ischemia/reperfusion. Beneficial effects of blocking anion channels could result from inhibiting the influx of • O 2g enerated extracellularry by neutrophils or other pathways; conversely, deleterious effects would be anticipated if intracellularly generated OFRs were to remain trapped in the cytosol. It is intriguing to speculate whether some of the beneficial effects of £-adrenergic receptor blockade during ischemia/reperfusion could be mediated by this mechanism since cardiac G' channels are highly regulated by /3-adrenergic receptors. £-Blockers are known to protect against OFR-induced injury in isolated canine myocytes, 79 but this may be due to a direct inhibition of OFR-induced lipid peroxidation. 80 On the other hand, some of the beneficial effects of OFR scavengers and inhibitors on reperfusion abnormalities may be due to nonspecific cardioprotective effects of these agents that are unrelated to their effects on OFR accumulation. 76 Recovery of cardiac function at an arbitrary time after reperfusion may also be a misleading index of efficacy since OFR inhibitors or scavengers may affect the time course but not the ultimate degree of recovery. This phenomenon has been described in several models of myocardial stunning, irreversible injury, or reperfusion arrhythmias in which the early beneficial effects of agents designed to scavenge or inhibit OFR production were not maintained.
7176 - 81 For example, SOD has been reported to have beneficial effects at reducing infarct size assessed after less than 6 hours of reperfusion in several canine and porcine coronary occlusion/reperfusion models.
14 -82 - 83 However, when recovery has been assessed after 4 days of reperfusion in similar models, the efficacy of PEG-SOD at reducing infarct size has been more inconsistent.
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The role of protection of vascular function by OFR inhibitors and scavengers during ischemia/reperfusion is unclear at the present time. OFR scavengers have been shown to attenuate the defect in endothelium-derived relaxing factor metabolism characteristic of reperfused myocardium and to reduce vascular plugging by white cells and no-reflow. 84 - 85 Whether this has important effects in the ultimate recovery of overall postischemic cardiac function is not yet established.
Clinical Relevance
A clinical role for the use of OFR scavengers or inhibitors in ischemic heart disease is still evolving. At the present time, OFR scavengers and inhibitors have been successfully tested for use in cardioplegic solutions designed to promote the preservation of transplanted organs 86 and to protect the myocardium during circulatory arrest during open heart surgery. 87 In the case of elective surgery, administering an antioxidant agent before an ischemic period is easily facilitated. Whether OFR scavengers and inhibitors can also be of benefit during acute coronary syndromes remains to be seen. It is likely that for maximum benefit to be achieved, the antioxidant agent would have to be administered before reperfusion to effectively cope with the initial free radical "burst." This may be one factor accounting for the disappointing results of a recent pilot study evaluating the effects of OFR scavenger infusion delivered at the time of reperfusion on infarct size in patients undergoing PTCA for acute myocardial infarction. nary artery bypass graft surgery through administration of modified reperfusate to the ischemic zone. During PTCA, application of OFR scavengers or inhibitors to the myocardium before reperfusion is more problematic, but retroperfusion of antioxidants via the coronary sinus could be a potential route of administration. With intravenous thrombolytic therapy, pretreatment with antioxidants is not practical.
Before it is appropriate to introduce such measures into the clinical management of ischemic heart disease, however, the conditions under which prevention of OFR accumulation during myocardial ischemia/reperfusion has major benefits must be clarified more precisely. The multifactorial nature of myocardial ischemia/ reperfusion abnormalities makes this a very challenging task.
